Medical Cannabis Act: Ministry of Health publishes stakeholder responses to amendment draft
2025-10-07 | The Federal Ministry of Health (BMG) has published the statements of associations and stakeholders on the draft amendment to the Medical Cannabis Act (MedCanG) following a freedom of information request. All statements can be found here:
Federal Union of German Associations of Pharmacists (ABDA)
Working Group on Cannabis as Medicine (ACM)
German Medical Association (BAEK)
German Society of Anaesthesiology and Intensive Care Medicine (DGAI) and the Professional Association of German Anaesthetists (BDA)
Federal Association of German Cannabis Patients (BDCan)
Federal Association of Pharmaceutical Cannabinoid Companies (BPC)
Federal Association of the Pharmaceutical Industry (BPI)
German Cannabis Industry Association (BvCW)
Cannabis Cultivation Associations of Germany (CAD e.V.)
German Society for Paediatrics and Adolescent Medicine (DGKJ)
German Society for Psychiatry and Psychotherapy, Psychosomatics and Neurology (DGPPN)
German Centre for Addiction Issues (DHS)
German Hemp Association (DHV)
German Pain Society (DGS)
National Association of Statutory Health Insurance Funds (GKV-SV)
Mariana Cannabis Social Clubs Germany e.V.
Pharma Germany
Association of Cannabis-Supplying Pharmacies (VCA)
Source: German Cannabis Business Association Newsletter
